Moreover, patients with tubal, peritoneal, and ovarian cancer show a decreased level of plasma-derived naturally circulating anti-P1 IgM antibody, and this observation can be applied in biochemical diagnosis of gynecological tumors [99]. This evidence concerns the gene A4GALT and ovarian carcinoma.